Sanofi India CFO Rachid Ayari to Step Down on Sept 30

MUMBAI — Healthcare major Sanofi India Limited has formally notified Indian stock exchanges that Mr. Rachid Ayari will relinquish his responsibilities as Whole-Time Director and Chief Financial Officer (CFO) of the company, effective at the close of business hours on September 30, 2026.

According to regulatory filings submitted under Regulation 30 of the Securities and Exchange Board of India (SEBI) Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, Mr. Ayari submitted his formal resignation following his assignment to a new international role within the broader Sanofi corporate network. The company confirmed that his resignation was tendered solely due to this internal group transition.

Executive Background and Transition Roadmap

Mr. Rachid Ayari has accumulated over two decades of financial leadership experience in the global pharmaceutical industry, having previously held senior regional finance positions across North Africa, Russia, Central Asia, and India.

Key executive milestones during his tenure at Sanofi India include:

• Executive Leadership: Appointed as Chief Financial Officer and Whole-Time Director, managing financial planning, regulatory compliance, and capital allocation.

• Interim Managing Director: Served as Interim Managing Director of Sanofi India Limited from July 21, 2025, to October 26, 2025, facilitating leadership continuity prior to the appointment of Managing Director Deepak Arora.

• Corporate Demerger Oversight: Supported structural compliance during the corporate demerger and listing of Sanofi Consumer Healthcare India Limited.

Sanofi India confirmed that Mr. Ayari will remain fully active in his managerial capacities until September 30, 2026, to ensure an orderly handover of financial and administrative operations.

Succession Planning and Corporate Governance

The Nomination and Remuneration Committee along with the Board of Directors of Sanofi India Limited have initiated the selection process to identify a qualified successor for the Chief Financial Officer and Key Managerial Personnel (KMP) roles.

Company management assured shareholders that statutory announcements regarding the appointment of the new CFO will be made in due course, adhering strictly to SEBI LODR timelines and corporate governance standards.

Official Sources Section

The corporate information and transition metrics outlined in this article are derived directly from official regulatory filings, statutory notices, and press announcements published by:

• Sanofi India Limited Regulatory Filings submitted under SEBI LODR Regulations.

• National Stock Exchange of India (NSE) corporate disclosures under ticker SANOFI.

• BSE Limited Listing Disclosures corporate announcements under scrip code 500674.

Quote Section

According to official filings submitted by Sanofi India Limited to stock exchanges:

"Mr. Rachid Ayari has communicated his decision to step down from the position of Whole-Time Director and Chief Financial Officer of the Company with effect from the close of business hours on September 30, 2026, pursuant to his transition to a new role within the Sanofi group. The Board places on record its sincere appreciation for his valuable contributions during his tenure."

Why It Matters

• For Equity Investors: Provides transparent advance notice regarding key managerial transitions at a major listed pharmaceutical firm.

• For Corporate Governance: Demonstrates structured succession planning and clear alignment with SEBI disclosure standards.

• For Healthcare Industry: Highlights ongoing mobility and talent deployment within global healthcare conglomerates.

Key Facts at a Glance

• Executive Action: Rachid Ayari resigns as Whole-Time Director and CFO.

• Effective Date: Close of business hours on September 30, 2026.

• Reason for Change: Appointment to a new role within the global Sanofi group.

• Regulatory Compliance: Disclosed under Regulation 30 of SEBI LODR Regulations, 2015.

• Listing Details: Sanofi India Limited trades on the NSE (SANOFI) and BSE (500674).

Frequently Asked Questions (FAQs)

When will Rachid Ayari step down as CFO of Sanofi India?

Mr. Rachid Ayari will formally step down from his role as Whole-Time Director and Chief Financial Officer on September 30, 2026.

Why is Rachid Ayari stepping down from Sanofi India?

His resignation follows his assignment to a new global leadership role within the Sanofi group.

Who will succeed Rachid Ayari as CFO of Sanofi India?

The company’s Board of Directors is currently conducting a selection process and will announce a successor once finalized.

Where are Sanofi India shares traded?

Equity shares of Sanofi India Limited are listed and traded on the National Stock Exchange of India (NSE) under ticker SANOFI and BSE Limited under scrip code 500674.

Source: Official announcements from Sanofi India Limited, regulatory filings on the National Stock Exchange of India (NSE), and listing disclosures on BSE Limited.